name:-0.023698091506958
name:-0.0070090293884277
name:-0.013859987258911
GENMAB B.V. Patent Filings

GENMAB B.V.

Patent Applications and Registrations

Patent applications and USPTO patent grants for GENMAB B.V..The latest application filed is for "anti-dr5 antibodies and methods of use thereof".

Company Profile
18.8.20
  • GENMAB B.V. - Utrecht N/A NL
  • GENMAB B.V. - Copenhagen K DK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Dimeric protein with triple mutations
Grant 11,180,572 - De Jong , et al. November 23, 2
2021-11-23
Anti-dr5 Antibodies And Methods Of Use Thereof
App 20210324096 - OVERDIJK; Marije ;   et al.
2021-10-21
Antibody Variant Combinations And Uses Thereof
App 20210238296 - DE JONG; Rob ;   et al.
2021-08-05
Dimeric Protein With Triple Mutations
App 20210230301 - DE JONG; Rob N. ;   et al.
2021-07-29
Antibody Variants And Uses Thereof
App 20210163619 - PARREN; Paul ;   et al.
2021-06-03
Polypeptide Variants And Uses Thereof
App 20210107988 - OOSTINDIE; Simone ;   et al.
2021-04-15
Anti-DR5 antibodies and methods of use thereof
Grant 10,882,913 - Overdijk , et al. January 5, 2
2021-01-05
Anti-dr5 Family Antibodies, Bispecific Or Multivalent Anti-dr5 Family Antibodies And Methods Of Use Thereof
App 20200332016 - Vermot-Desroches; Claudine Brigitte Fernande ;   et al.
2020-10-22
Antibody variants and uses thereof
Grant 10,759,867 - Parren , et al. Sep
2020-09-01
Therapeutic Antibodies Based On Mutated Igg Hexamers
App 20200247897 - Kind Code
2020-08-06
Polypeptide Variants And Uses Thereof
App 20200181277 - BEURSKENS; Frank ;   et al.
2020-06-11
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof
Grant 10,647,774 - Vermot-Desroches , et al.
2020-05-12
Antibodies And Methods Of Use Thereof In Treatment Of Infectious Disease
App 20200123237 - KUIPERS; Annemarie ;   et al.
2020-04-23
Anti-dr5 Antibodies And Methods Of Use Thereof
App 20190315877 - OVERDIJK; Marije ;   et al.
2019-10-17
Polypeptide Variants And Uses Thereof
App 20190276549 - DE JONG; Rob ;   et al.
2019-09-12
Anti-death Receptor Antibodies And Methods Of Use Thereof
App 20190202926 - BEURSKENS; Frank ;   et al.
2019-07-04
Anti-dr5 Antibodies And Methods Of Use Thereof
App 20190144554 - OVERDIJK; Marije ;   et al.
2019-05-16
Anti-dr5 Family Antibodies, Bispecific Or Multivalent Anti-dr5 Family Antibodies And Methods Of Use Thereof
App 20170260281 - Vermot-Desroches; Claudine Brigitte Fernande ;   et al.
2017-09-14
Anti-DR5 family antibodies, bispecific or multivalent anti-DR5 family antibodies and methods of use thereof
Grant 9,611,327 - Vermot-Desroches , et al. April 4, 2
2017-04-04
Human Igg1 Fc Region Variants And Uses Thereof
App 20150353636 - PARREN; Paul ;   et al.
2015-12-10
Inert Format
App 20150337049 - LABRIJN; Aran Frank ;   et al.
2015-11-26
Dimeric Protein With Triple Mutations
App 20150175707 - De Jong; Rob N. ;   et al.
2015-06-25
Antibody Variants And Uses Thereof
App 20140242075 - Parren; Paul ;   et al.
2014-08-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed